Park West Asset Management LLC Buys New Stake in Synopsys, Inc. $SNPS

Park West Asset Management LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 70,900 shares of the semiconductor company’s stock, valued at approximately $31,626,000. Synopsys makes up about 2.2% of Park West Asset Management LLC’s investment portfolio, making the stock its 21st largest position.

A number of other institutional investors have also recently made changes to their positions in the business. Sankala Group LLC purchased a new stake in shares of Synopsys during the fourth quarter worth about $25,000. Elevation Wealth Partners LLC grew its position in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the last quarter. Osbon Capital Management LLC acquired a new position in Synopsys during the 2nd quarter valued at approximately $25,000. IMG Wealth Management Inc. purchased a new position in shares of Synopsys in the second quarter worth $28,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the fourth quarter valued at $28,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Stock Up 0.3%

SNPS opened at $410.00 on Thursday. The company has a fifty day moving average of $416.71 and a two-hundred day moving average of $439.84. The stock has a market capitalization of $78.51 billion, a price-to-earnings ratio of 94.91, a PEG ratio of 2.40 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s quarterly revenue was up 42.4% on a year-over-year basis. During the same period last year, the firm earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q3 revenue of $2.477 billion, up 42.4% year over year, while non-GAAP EPS of $3.91 exceeded the $3.67 consensus estimate. Design Automation was the primary contributor, indicating broad demand for chip-design software. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026
  • Positive Sentiment: Management raised its fiscal 2026 outlook to approximately $9.715 billion in revenue and $15.07 in non-GAAP EPS at the midpoints. The company also projected fourth-quarter EPS of $4.10-$4.16, above the $3.78 analyst consensus, citing continued AI-driven demand and benefits from the Ansys business. Synopsys raises annual forecasts on AI-driven chip design software demand
  • Positive Sentiment: Synopsys continues to position AI as a growth driver, saying customers are achieving substantial productivity gains and that engineering workflows are moving toward more autonomous systems. Nvidia’s reported $2 billion investment in Synopsys also reinforces the strategic importance of AI-powered design and simulation. Nvidia’s $2 Billion Synopsys Bet Signals AI’s Next Frontier
  • Neutral Sentiment: Analyst sentiment remains favorable: Rosenblatt reaffirmed a Buy rating and set a $575 price target. However, SNPS trades at a high earnings multiple, leaving the shares sensitive to guidance, execution and valuation concerns. Rosenblatt Reiterates Buy Rating on Synopsys
  • Negative Sentiment: The stock declined even after the earnings beat and guidance increase. The reaction indicates that strong results may already have been priced in, while full-year revenue guidance was broadly aligned with expectations and fourth-quarter revenue guidance of $2.53-$2.58 billion did not clearly exceed consensus. Synopsys slides even as it boosts full-year guidance

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SNPS. Needham & Company LLC restated a “buy” rating and issued a $580.00 target price on shares of Synopsys in a research note on Thursday, May 28th. Stifel Nicolaus raised their price objective on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Wells Fargo & Company reduced their price target on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 11th. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research note on Wednesday, May 27th. Finally, BNP Paribas Exane upped their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Eleven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $563.71.

Get Our Latest Report on Synopsys

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.